See more : thyssenkrupp AG (TKA.DE) Income Statement Analysis – Financial Results
Complete financial analysis of Cogstate Limited (COGZF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cogstate Limited, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- HeidelbergCement India Limited (HEIDELBERG.BO) Income Statement Analysis – Financial Results
- Graycliff Exploration Limited (GRYCF) Income Statement Analysis – Financial Results
- NovaGold Resources Inc. (NG.TO) Income Statement Analysis – Financial Results
- Exro Technologies Inc. (1O2.F) Income Statement Analysis – Financial Results
- SMA Solar Technology AG (SMTGF) Income Statement Analysis – Financial Results
Cogstate Limited (COGZF)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.cogstate.com
About Cogstate Limited
Cogstate Limited, a neuroscience technology company, provides computerized cognitive tests and electronic clinical outcome assessment solutions. The company's cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist primary care physicians and/or hospitals in the early detection of cognitive decline. As of June 30, 2022, it had participated in approximately 1,800 academic research. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 43.43M | 60.14M | 62.03M | 43.82M | 33.97M | 30.53M | 37.37M | 35.01M | 27.25M | 12.33M | 11.55M | 11.37M | 12.30M | 8.69M | 8.06M | 6.77M | 3.62M | 1.99M | 1.54M | 782.15K | 134.30K | 203.74K |
| Cost of Revenue | 18.72M | 47.85M | 40.39M | 33.42M | 32.00M | 28.42M | 29.87M | 29.84M | 21.98M | 6.05M | 6.44M | 5.01M | 1.35M | 832.37K | 1.22M | 485.73K | 100.73K | 147.67K | 192.15K | 0.00 | 0.00 | 0.00 |
| Gross Profit | 24.71M | 12.29M | 21.63M | 10.40M | 1.96M | 2.11M | 7.51M | 5.18M | 5.28M | 6.28M | 5.11M | 6.36M | 10.94M | 7.86M | 6.84M | 6.29M | 3.52M | 1.85M | 1.35M | 782.15K | 134.30K | 203.74K |
| Gross Profit Ratio | 56.89% | 20.43% | 34.88% | 23.74% | 5.78% | 6.91% | 20.08% | 14.78% | 19.36% | 50.92% | 44.25% | 55.92% | 88.99% | 90.42% | 84.82% | 92.83% | 97.22% | 92.59% | 87.53% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 10.66M | 8.61M | 999.77K | 746.68K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 21.37K | 52.07K | 161.41 | 143.51 | 90.46K | 176.09K | 198.48K | 28.50K | 0.00 |
| General & Administrative | 13.61M | 14.41M | 11.80M | 10.26M | 8.43M | 13.70M | 15.86M | 12.32M | 9.27M | 7.39M | 7.18M | 6.40M | 7.31M | 6.44M | 4.82M | 4.31M | 3.58M | 2.74M | 2.31M | 1.88M | 1.15M | 842.02K |
| Selling & Marketing | 17.41K | 73.55K | 38.54K | 106.67K | 163.71K | 246.24K | 445.38K | 460.79K | 526.10K | 381.02K | 439.47K | 329.15K | 503.50K | 327.89K | 119.77K | 80.21K | 101.23K | 115.31K | 93.38K | 297.28K | 67.22K | 45.27K |
| SG&A | 13.63M | 8.88M | 6.54M | 5.26M | 6.18M | 7.60M | 7.26M | 5.66M | 4.45M | 7.77M | 7.62M | 6.73M | 7.81M | 6.77M | 4.94M | 4.39M | 3.68M | 2.85M | 2.40M | 2.17M | 1.22M | 887.29K |
| Other Expenses | 11.08M | 140.86K | -132.49K | 2.07M | -13.09K | 2.06M | 2.34M | -245.93K | 242.16K | 979.25K | 113.29K | 355.57K | 1.54M | -166.45K | 77.24K | 489.77K | -25.50K | 65.15K | 157.89K | 212.90K | 38.81K | 206.32K |
| Operating Expenses | 24.71M | 8.88M | 6.54M | 5.26M | 6.18M | 7.60M | 7.26M | 5.66M | 4.45M | 9.60M | 9.60M | 8.59M | 9.47M | 8.09M | 6.61M | 5.80M | 4.49M | 3.53M | 2.99M | 3.16M | 1.70M | 1.29M |
| Cost & Expenses | 43.43M | 56.73M | 46.93M | 38.68M | 38.19M | 36.02M | 37.13M | 35.49M | 26.43M | 15.65M | 16.04M | 14.91M | 10.58M | 8.35M | 9.22M | 7.79M | 4.74M | 4.33M | 4.30M | 3.16M | 1.70M | 1.29M |
| Interest Income | 0.00 | 1.04M | 73.21K | 13.67K | 17.88K | 27.37K | 50.07K | 74.46K | 79.79K | 91.20K | 168.45K | 125.73K | 159.30K | 122.70K | 86.17K | 85.29K | 56.55K | 89.04K | 106.89K | 168.50K | 99.32K | 5.92K |
| Interest Expense | 51.22K | 103.75K | 121.73K | 119.74K | 227.65K | 117.46K | 96.13K | 59.73K | 49.13K | 85.62K | 70.38K | 52.00K | 52.43K | 36.02K | 49.08K | 18.15K | 49.68K | 139.54K | 63.80K | 0.00 | 190.09K | 20.91K |
| Depreciation & Amortization | 2.74M | 3.86M | 3.20M | 3.08M | 3.00M | 692.77K | 841.10K | 1.02M | 869.24K | 565.00K | 644.61K | 649.32K | 599.63K | 452.36K | 367.89K | 207.73K | 121.23K | 76.94K | 49.55K | 86.96K | 63.95K | 57.42K |
| EBITDA | 9.89M | 8.46M | 18.07M | 8.21M | -1.22M | -4.80M | 1.07M | 542.07K | 1.57M | -3.35M | -3.86M | -948.33K | 3.63M | 164.20K | 739.83K | 1.27M | -800.08K | -1.45M | -1.80M | -2.29M | -1.37M | -816.03K |
| EBITDA Ratio | 22.78% | 12.09% | 29.50% | 18.76% | -3.60% | -15.71% | 2.90% | 1.55% | 6.20% | -13.70% | -30.87% | -7.15% | 28.55% | -5.67% | 9.18% | 18.73% | -22.86% | -72.80% | -86.81% | -293.22% | -1,018.02% | -400.52% |
| Operating Income | 989.75K | 3.41M | 15.09M | 5.14M | -4.22M | -5.49M | 242.11K | -481.06K | 821.63K | -2.25M | -4.21M | -2.45M | 1.43M | -218.11K | 267.17K | 598.61K | -959.23K | -1.83M | -2.23M | -3.12M | -2.24M | -1.61M |
| Operating Income Ratio | 2.28% | 5.67% | 24.34% | 11.72% | -12.42% | -17.98% | 0.65% | -1.37% | 3.01% | -18.28% | -36.45% | -21.50% | 11.66% | -2.51% | 3.31% | 8.84% | -26.50% | -91.98% | -144.48% | -399.13% | -1,667.79% | -788.77% |
| Total Other Income/Expenses | 9.66M | 1.09M | 659.35K | 1.23M | -2.10M | -20.92K | -105.03K | -396.01K | -45.89K | -273.93K | 211.36K | 785.23K | 1.39M | -763.44K | 55.69K | 443.46K | -39.25K | -133.91K | 270.84K | 276.37K | -79.02K | 188.48K |
| Income Before Tax | 10.65M | 4.50M | 14.74M | 7.80M | -4.47M | -5.38M | 137.08K | -877.07K | 492.70K | -4.00M | -4.28M | -1.51M | 2.86M | -981.55K | 322.86K | 1.04M | -998.48K | -1.67M | -1.45M | -2.00M | -1.62M | -894.36K |
| Income Before Tax Ratio | 24.52% | 7.48% | 23.77% | 17.81% | -13.15% | -17.64% | 0.37% | -2.51% | 1.81% | -32.44% | -37.06% | -13.32% | 23.24% | -11.29% | 4.01% | 15.39% | -27.58% | -83.71% | -94.17% | -255.57% | -1,207.18% | -438.97% |
| Income Tax Expense | 2.48M | -806.70K | 4.38M | 786.90K | -1.55M | -1.89M | 867.45K | -24.01K | -2.15M | -116.30K | -618.36K | 271.40K | 348.30K | -77.16K | -1.07M | -111.72K | -284.27K | -266.20K | -261.15K | -2.00M | -1.62M | -894.36K |
| Net Income | 5.45M | 5.30M | 10.37M | 7.02M | -2.92M | -3.49M | -730.37K | -853.06K | 2.64M | -3.88M | -3.66M | -1.79M | 2.51M | -904.39K | 1.39M | 1.15M | -714.21K | -1.40M | -1.19M | -1.70M | -1.83M | -883.89K |
| Net Income Ratio | 12.55% | 8.82% | 16.72% | 16.01% | -8.59% | -11.43% | -1.95% | -2.44% | 9.69% | -31.49% | -31.70% | -15.70% | 20.41% | -10.40% | 17.27% | 17.04% | -19.73% | -70.36% | -77.21% | -216.83% | -1,365.45% | -433.83% |
| EPS | 0.03 | 0.03 | 0.06 | 0.04 | -0.02 | -0.03 | -0.01 | -0.01 | 0.02 | -0.04 | -0.04 | -0.02 | 0.03 | -0.01 | 0.02 | 0.02 | -0.01 | -0.03 | -0.03 | -0.05 | -0.09 | -0.03 |
| EPS Diluted | 0.03 | 0.03 | 0.06 | 0.04 | -0.02 | -0.03 | -0.01 | -0.01 | 0.02 | -0.04 | -0.04 | -0.02 | 0.03 | -0.01 | 0.02 | 0.02 | -0.01 | -0.03 | -0.03 | -0.05 | -0.09 | -0.03 |
| Weighted Avg Shares Out | 173.01M | 173.44M | 172.77M | 173.06M | 159.36M | 119.20M | 115.20M | 113.85M | 114.87M | 99.26M | 90.43M | 75.28M | 74.54M | 67.53M | 66.92M | 64.76M | 51.20M | 45.42M | 39.56M | 36.62M | 20.00M | 33.54M |
| Weighted Avg Shares Out (Dil) | 173.10M | 176.34M | 176.82M | 173.06M | 159.36M | 119.20M | 115.20M | 113.85M | 117.45M | 100.17M | 90.53M | 77.18M | 74.54M | 67.53M | 70.43M | 66.26M | 51.20M | 45.42M | 39.56M | 36.62M | 20.00M | 33.54M |
Cogstate Expands Alzheimer's Disease Leadership with Appointment of Dr. Kaycee Sink, as Chief Medical Officer
Cogstate Limited (COGZF) Q4 2024 Earnings Call Transcript
Cogstate Limited (COGZF) Q4 2022 Earnings Call Transcript
Cogstate Limited (COGZF) CEO Brad O'Connor on Q4 2022 Results - Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports